A carregar...

Platelet inhibition with Ticlopidine in atherosclerotic intermittent claudication.

Fifty-one men with atherosclerotic intermittent claudication and haemorheological abnormalities completed a double-blind, one-year randomised trial of Ticlopidine (500 mg/day), a new antiplatelet agent. Ticlopidine caused significant inhibition of platelet aggregation but did not fully correct abnor...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Aukland, A, Hurlow, R A, George, A J, Stuart, J
Formato: Artigo
Idioma:Inglês
Publicado em: 1982
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC497768/
https://ncbi.nlm.nih.gov/pubmed/7047575
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!